SEC Form 4 · accession 0000899243-18-031706
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin D. Gover
Officer — Chief Executive Officer · Director
Period of report
Dec 20, 2018
Accepted (ET)
Dec 26, 2018 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Dec 20, 2018 | M | 45,240 | $0.0013 | A | 415,685 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3,F2,F4 | $0.0013 | Dec 20, 2018 | M | 45,240 | D | — | Dec 24, 2018 | Ordinary Shares | 45,240 | 0 | D |
Explanation of responses
- F1Exercise of stock options. These ordinary shares are represented by 3,770 American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.2662 U.S. Dollars as of December 20, 2018.
- F3Exercise of stock options. Following the exercise, these shares were converted into 3,770 ADSs.
- F4Granted pursuant to the Issuer's Long-Term Incentive Plan and fully vested.